+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United Kingdom Orthobiologics Market Outlook to 2025

  • PDF Icon

    Report

  • 81 Pages
  • July 2018
  • Region: United Kingdom
  • GlobalData
  • ID: 4601723
United Kingdom Orthobiologics Market Outlook to 2025

Summary

The author's new report, United Kingdom Orthobiologics Market Outlook to 2025, provides key market data on the United Kingdom Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Orthobiologics market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

  • 2017 company share and distribution share data for Orthobiologics market.

  • Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics market.

  • Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.


Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 OrthobiologicsMarket Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United Kingdom
3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2015-2025
3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2015-2025
3.3 Orthobiologics Market, United Kingdom, Average Price ($), 2015-2025
3.4 Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2017
3.5 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United Kingdom, Orthobiologics Market
4.1 Medtronic Plc
4.2 Sanofi
4.3 DePuy Synthes Inc
4.4 Stryker Corp
4.5 Zimmer Biomet Holdings Inc
4.6 Fidia farmaceutici SpA
4.7 DJO Global Inc
4.8 Anika Therapeutics Inc
4.9 ConMed Corporation
4.10 Biocomposites Ltd
4.11 TRB Chemedica International SA
4.12 RTI Surgical Inc
4.13 Bioventus LLC
4.14 Orthofix Holdings Inc
5 Orthobiologics Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.2 Private Equity
7 Recent Developments
7.1 Corporate Communications
7.2 Financial Announcements
7.3 Other Significant Developments
7.4 Product News
8 Appendix
8.1 Research Methodology
8.2 Consulting
8.3 Contact
8.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 2: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 3: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 4: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 5: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 6: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 7: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 8: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 9: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 10: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 11: Orthobiologics Market, United Kingdom, Volume (Units), 2015-2020
Table 12: Orthobiologics Market, United Kingdom, Volume (Units), 2021-2025
Table 13: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2015-2020
Table 14: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2021-2025
Table 15: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2015-2020
Table 16: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2021-2025
Table 17: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2015-2020
Table 18: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2021-2025
Table 19: Viscosupplementation Market, United Kingdom, Volume (Units), 2015-2020
Table 20: Viscosupplementation Market, United Kingdom, Volume (Units), 2021-2025
Table 21: Orthobiologics Market, United Kingdom, Average Price ($), 2015-2020
Table 22: Orthobiologics Market, United Kingdom, Average Price ($), 2021-2025
Table 23: Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2017
Table 24: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2017
Table 25: Orthobiologics Market Pipeline Products
Table 26: AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million
Table 27: Elliott Management May Acquire Stake in Smith & Nephew
Table 28: Saratoga Partners Acquires Orteq Sports Medicine
Table 29: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 4: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 5: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 6: Orthobiologics Market, United Kingdom, Volume (Units), 2015-2025
Figure 7: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2015-2025
Figure 8: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2015-2025
Figure 9: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2015-2025
Figure 10: Viscosupplementation Market, United Kingdom, Volume (Units), 2015-2025
Figure 11: Orthobiologics Market, United Kingdom, Company Share (%) 2017

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Sanofi
  • DePuy Synthes Inc
  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • Fidia farmaceutici SpA
  • DJO Global Inc
  • Anika Therapeutics Inc
  • ConMed Corporation
  • Biocomposites Ltd
  • TRB Chemedica International SA
  • RTI Surgical Inc
  • Bioventus LLC
  • Orthofix Holdings Inc